EXOASO-C/EBP beta(TM): AN ENGINEERED EXOSOME THERAPEUTIC THAT SELECTIVELY TARGETS MDSCS AND INDUCES POTENT SINGLE-AGENT ANTI-TUMOR ACTIVITY IN CHECKPOINT REFRACTORY TUMOR MODELS
JOURNAL FOR IMMUNOTHERAPY OF CANCER（2022）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要